SpainSpain

Coping with a sea of data

08.03.2012

Granada-based Integromics S.L. has teamed up with the Galician Foundation of Genomic Medicine (FPGMX) in Santiago de Compostela to secure a €1m EU grant from the European Regional Development Fund and the Spanish government. With the advent of cheap sequencing technologies, the bulk interpretation of generated data has become more vital than ever. The joint project is entitled “Advanced analysis and interpretation of low-cost next-generation sequencing data for clinical applications” (ApliClinics LC-NGS). While FPGMX brings expertise in the field of clinical genomics to the partner­ship, Integromics will be in charge of bioinformatics. Its CSO Eduardo González Couto calls the collaboration a pioneering effort for Integromics: “This will be the first time that we are working side-by-side with clinicians to bridge the gap between NGS technology and healthcare for patients.” FPGMX director Àngel Carracedo, who has a staff of 92 at the University of Santiago (USC), says that the bottleneck is not data production but “the bioinformatic tools that allow us to obtain reliable and accurate information on the variation found after DNA sequencing.” The first results – in the form of software and lab procedures – are expected this fall.

SpainSpain

12.05.2010

Madrid – In the last few years, the number of companies interested in mining marine life for interesting substances has risen steadily. Madrid-based Pharmamar was one of the first, and is also one of the very few to have a...

SpainSpain

11.05.2010

Pamplona – From Sept. 29th-Oct. 1st, Pamplona will become the centre of the European biotechnology world when the city famous for the annual running of the bulls through the medieval town centre hosts the BioSpain 2010. The...

SpainSpain

07.03.2010

San Sebastian – Europe has to unify its research efforts and infrastructures if it doesn’t want to be overtaken by Asian competitors such as China in the mid-term – that was Spanish Science Minister Cristina Garmendia’s message...

SpainSpain

07.03.2010

Madrid/Rockville – Spain’s Rovi Pharmaceuticals has terminated talks with US vaccine specialist Novavax Inc. to license recombinant virus-like particle (VLP) vaccine technology to help Spain meet its seasonal and pandemic flu...

SpainSpain

01.02.2010

Barcelona – Ferrer inCode has agreed to distribute DiaGenic’s blood-based ADtect test for the early diagnosis of Alzheimer’s Disease. The agreement with the Oslo-based company gives Ferrer inCode, a biotech subsidiary of Grupo...

SpainSpain

01.02.2010

Seville – Scientists at the University of Seville have published the first demographic map of colon cancer in Spain. The analysis examines Spanish trends between 1951-2006 in terms of particular changes in consumption patterns...

SpainSpain

01.02.2010

Madrid – A goundbreaking technique that promised to speed up the discovery of novel microbial enzymes from environmental samples has come in for criticism. Soon after scientists from Spain, Germany, and the UK had presented their...

SpainSpain

27.11.2009

Barcelona/Heidelberg – US genome pioneer Craig Venters’ plan to create a minimal synthetic cell based on the essential genes of Mycoplasma bacteria may ultimately be too ambitious. A brand new study conducted by a team of...

Portugal, SpainSpain

01.09.2009

Madrid/Oviedo – Over 400,000 people are diagnosed with colorectal cancer every year in Europe. It is the second most common type of cancer in women, and the third most common in men, killing over 200,000 people annually. That...

Displaying results 31 to 40 out of 181

< Previous 31-40 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-spain/browse/3/article/coping-with-a-sea-of-data.html

Events

All Events

Stock list

All quotes

TOP

  • CHRONTECH PHARMA (S)0.09 SEK12.50%
  • WILEX (D)2.99 EUR6.79%
  • CO.DON (D)2.75 EUR5.77%

FLOP

  • ANTISOMA (UK)1.32 GBP-14.84%
  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.29%
  • SERODUS (N)2.81 NOK-10.79%

TOP

  • WILEX (D)2.99 EUR251.8%
  • ADDEX (CH)3.82 CHF59.2%
  • 4SC (D)1.45 EUR49.5%

FLOP

  • HYBRIGENICS (F)1.72 EUR-29.5%
  • PROSENSA (NL)9.72 USD-23.4%
  • PROTHENA PLC (IE)17.37 USD-22.1%

TOP

  • SANTHERA (CH)64.00 CHF3022.0%
  • GW PHARMACEUTICALS (UK)426.00 GBP654.0%
  • PAION (D)2.67 EUR292.6%

FLOP

  • EVOCUTIS (UK)0.21 GBP-92.2%
  • CYTOS (CH)0.28 CHF-91.8%
  • THROMBOGENICS (B)9.14 EUR-70.6%

No liability assumed, Date: 29.07.2014


Current issue

All issues

Product of the week

Products